Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
European Journal of Clinical Nutrition
|
May 29, 2003
Safety of long-term consumption of plant sterol esters-enriched spread
H F J Hendriks, E J Brink, G W Meijer, et al.
Atherosclerosis
|
December 17, 2002
Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus
M A van de Ree, M V Huisman, H M G Princen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 29, 2006
Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol
T Kooistra, L Verschuren, J de Vries-van der Weij, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 13, 2003
Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus
M A Van De Ree, M P M De Maat, C Kluft, et al.
British Journal of Pharmacology
|
February 18, 2009
The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice
J W A van der Hoorn, J W Jukema, L M Havekes, et al.
European Journal of Human Genetics : EJHG
|
July 9, 2004
Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals
M K Hofman, M Groenendijk, P J J H Verkuijlen, et al.
Annals of the Rheumatic Diseases
|
April 30, 2013
Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice--a translational model for atherosclerosis
L M Gierman, S Kühnast, A Koudijs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 28, 2005
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice
A Trion, M P M de Maat, J W Jukema, et al.
Osteoarthritis and Cartilage
|
November 28, 2022
IL-1β inhibition combined with cholesterol-lowering therapies decreases synovial lining thickness and spontaneous cartilage degeneration in a humanized dyslipidemia mouse model
Y van Gemert, N N L Kruisbergen, A B Blom, et al.
Diabetes, Obesity & Metabolism
|
December 31, 2013
APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome
A M van den Hoek, J W A van der Hoorn, A C Maas, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
European Journal of Clinical Nutrition
|
May 29, 2003
Safety of long-term consumption of plant sterol esters-enriched spread
H F J Hendriks, E J Brink, G W Meijer, et al.
Atherosclerosis
|
December 17, 2002
Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus
M A van de Ree, M V Huisman, H M G Princen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 29, 2006
Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol
T Kooistra, L Verschuren, J de Vries-van der Weij, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 13, 2003
Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus
M A Van De Ree, M P M De Maat, C Kluft, et al.
British Journal of Pharmacology
|
February 18, 2009
The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice
J W A van der Hoorn, J W Jukema, L M Havekes, et al.
European Journal of Human Genetics : EJHG
|
July 9, 2004
Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals
M K Hofman, M Groenendijk, P J J H Verkuijlen, et al.
Annals of the Rheumatic Diseases
|
April 30, 2013
Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice--a translational model for atherosclerosis
L M Gierman, S Kühnast, A Koudijs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 28, 2005
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice
A Trion, M P M de Maat, J W Jukema, et al.
Osteoarthritis and Cartilage
|
November 28, 2022
IL-1β inhibition combined with cholesterol-lowering therapies decreases synovial lining thickness and spontaneous cartilage degeneration in a humanized dyslipidemia mouse model
Y van Gemert, N N L Kruisbergen, A B Blom, et al.
Diabetes, Obesity & Metabolism
|
December 31, 2013
APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome
A M van den Hoek, J W A van der Hoorn, A C Maas, et al.
Page
of 2